BRUKINSA caps 80 mg bte 120 pce

8720598340105 Pharmacode 7829931 CH-67998 L01EL03
BRUKINSA caps 80 mg bte 120 pce
BRUKINSA caps 80 mg bte 120 pce
BRUKINSA caps 80 mg bte 120 pce
1 / 3
google

Details

GTIN
8720598340105
Pharmacode
7829931
Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
11/02/2026
Professional SmPC
Français
11/02/2026
Professional SmPC
Italien
11/02/2026
Patient information leaflet
Allemand
13/11/2025
Patient information leaflet
Français
13/11/2025
Patient information leaflet
Italien
13/11/2025

Detailed composition

Substance Quantity Type Category
zanubrutinibum
80.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
1.17 MG Substance HBESI

Authorization holder

BeOne Medicines I GmbH

4051 Basel

Authorization information

Swissmedic authorization number
67998
Drug name
Brukinsa, Hartkapseln
Galenic form
KAHA
ATC Code
L01EL03
Authorization status
Z
Dispensation category
A
First authorization
08/02/2022
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Morbus Waldenström, chronisch-lymphatische Leukämie (CLL), Follikuläres Lymphom

Packaging details

Description (FR)
BRUKINSA caps 80 mg bte 120 pce
Description (DE)
BRUKINSA Kaps 80 mg Ds 120 Stk
Market launch
08/02/2022
Narcotic (BTM)
No
Buy us a coffee Explore the data